-
National pharmacare by 2020 would cost $9.7 B in public funding but save more in total costs: analysis
A new analysis in CMAJ (Canadian Medical Association Journal) outlines the potential government cost of a national Canadian pharmacare program and sets out approaches to shifting the funding for drugs in Canada to realize billions in savings.